Company / PP&E per Share
Biogen PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$21.09
FY2025
5-year range
$19.61 / $22.51
FY2021-FY2025
Trend
-4.6%
vs FY2024
Sector context
#5 of 193
Health Care
What the data says
Among 193 Health Care companies, Biogen is in the top 3% for pp&e per share. PP&E per Share has fluctuated over the past 10 years, ranging from $11.44 in FY2016 to $22.51 in FY2023.
Based on SEC 10-K filings.
21.09 in FY2025 with a 5-year CAGR of +4.0%. Top quartile in the Health Care sector.
Declined from $22.51 to $21.09 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -0.9%
- 5-Year CAGR
- +4.0%
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 193This company $21.09 Sector average $18.71
▼
+12.7% above sector average
Key checks
Key Insights
- In FY2025, pp&e per share decreased 4.6% year-over-year.
- Ranks #5 out of 193 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2023.
- Lowest pp&e per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $21.09 | -4.6% |
| FY2024 | $22.09 | -1.9% |
| FY2023 | $22.51 | +4.0% |
| FY2022 | $21.64 | +10.4% |
| FY2021 | $19.61 | +13.4% |
| FY2020 | $17.30 | +12.7% |
| FY2019 | $15.35 | -8.0% |
| FY2018 | $16.68 | +13.2% |
| FY2017 | $14.74 | +28.8% |
| FY2016 | $11.44 | +22.7% |
As of FY2025 · SEC 10-K · Updated Mar 3, 2026